Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000450716

Medchemexpress LLC Seratrodast | 112665-43-7 | 99.6% | 25 MG
SDP

Catalog No. 5000450716
Encompass_Preferred

Seratrodast (AA 2414) is an orally active antiasthmatic agent, a thromboxane A2 receptor (TP) antagonist, and a ferroptosis inhibitor. It reduces lipid ROS production, modulates the systemic xc-/GSH/GPX4 axis, and inhibits JNK phosphorylation and p53 expression. This compound exhibits anti-asthmatic and anti-epileptic activity.

  • Thromboxane A2 receptor (TP) antagonist
  • Ferroptosis inhibitor
  • Reduces lipid ROS production
  • Modulates the systemic xc-/GSH/GPX4 axis
  • Inhibits JNK phosphorylation and p53 expression
  • Exhibits anti-asthmatic activity
  • Exhibits anti-epileptic activity
  • For research use only

Catalog No. 50-004-50716 Supplier Medchemexpress LLC Supplier No. 25MGHYB0774
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Seratrodast (AA 2414) is an orally active antiasthmatic agent, a thromboxane A2 receptor (TP) antagonist, and a ferroptosis inhibitor. It reduces lipid ROS production, modulates the systemic xc-/GSH/GPX4 axis, and inhibits JNK phosphorylation and p53 expression. This compound exhibits anti-asthmatic and anti-epileptic activity.

  • Thromboxane A2 receptor (TP) antagonist
  • Ferroptosis inhibitor
  • Reduces lipid ROS production
  • Modulates the systemic xc-/GSH/GPX4 axis
  • Inhibits JNK phosphorylation and p53 expression
  • Exhibits anti-asthmatic activity
  • Exhibits anti-epileptic activity
  • For research use only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.